Named Series: Diet, Inflammation and the Brain
Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice

https://doi.org/10.1016/j.bbi.2013.12.001Get rights and content

Highlight

  • Results from interleukin-18 knockout mice suggest that it may curb appetite and promote lipid utilization in healthy adults consuming high-fat diets.

Abstract

Objective

The proinflammatory cytokine interleukin-18 (IL-18) putatively modulates food intake and energy metabolism, but the effects of IL-18 in high-fat diet fed animals are unknown. Whether IL-18 alters basal metabolic rate or metabolic processes of living is unknown. Here, we tested the hypothesis that IL-18 modulates weight gain, energy intake, whole-body energy expenditure, and utilization of lipid as a fuel substrate in high-fat diet fed mice.

Methods

Food intake, whole-body metabolism, and motor activity of IL-18 knockout mice were compared to those of wildtype littermates; anorectic effects of intracerebroventricular IL-18 administration were compared between IL-18 receptor knockout, IL-18/IL-18R knockout and wildtype mice.

Results

Chow-reared IL-18 knockout mice were overweight at 6 months of age and then gained excess weight on both low-fat and high-fat diets, ate more high-fat diet, and showed reduced whole-body energy expenditure and increased respiratory exchange ratios. Reductions in energy expenditure of IL-18 knockout mice were seen across fasting vs. feeding conditions, low- vs. high-fat diets, high vs. low levels of physical activity and times of day, suggesting actions on basal metabolic rate. The circadian amplitude of energy expenditure, but not respiratory exchange ratio, food intake, or motor activity, also was blunted in IL-18 knockout mice. Central IL-18 administration reduced high-fat diet intake in wildtype mice, but not in mice lacking the IL-18 receptor.

Conclusion

The loss-of-function results support the hypothesis that endogenous IL-18 suppresses appetite and promote energy expenditure and lipid fuel substrate utilization not only during sickness, but also in healthy adults consuming high-fat diets.

Introduction

Better understanding the molecular controls of energy metabolism may inform the treatment of obesity. Interleukin-18 (IL-18), an 18 kDa multifunctional cytokine discovered for its proinflammatory and interferon-γ-inducing properties (Okamura et al., 1995), produces diverse effects via activation of the IL-18 receptor complex (Born et al., 2000, Torigoe et al., 1997), an IL-1/Toll-like superfamily receptor. Recent findings suggest that IL-18 may be a physiologic modulator of food intake and energy metabolism. Unlike classic proinflammtory cytokines that mediate the sickness response (e.g., IL-1β, IL-6, TNF-α), IL-18 also is constitutively expressed in non-immune cells and derived partly from adipocytes. Similar to other adipocytokines, its circulating levels relate to metabolic state, including fat mass, weight loss, hyperglycemia, and dietary fat intake (Esposito et al., 2002a, Esposito et al., 2002b, Esposito et al., 2003). Intracebrebroventricular or peripheral administration of IL-18 potently suppressed chow intake, feed efficiency and weight regain in fasted mice, without promoting sickness-like behavior (Zorrilla et al., 2007). Conversely, mice partially (Il18+/−) or totally deficient (IL18−/−) in IL-18 overate chow and purified low-fat diet by young adulthood (Zorrilla et al., 2007). Adult Il18−/− mice showed increased feed efficiency; indirect calorimetry revealed reduced energy expenditure in low-fat diet-fed female Il18−/− mice and increased respiratory exchange ratios (RER) (VCO2/VO2) in mutants of both sexes (Zorrilla et al., 2007). By mid-adulthood, Il18−/− mice became obese (Netea et al., 2006, Zorrilla et al., 2007). Similar delayed-onset obesity phenotypes were observed in IL-18 receptor knockout (KO) mice and in IL-18-binding protein overexpressing mice (Netea et al., 2006).

The present studies sought to determine the effects of the IL-18 null genotype in mice fed high-fat diet. Previous calorimetry studies in IL-18 KO mice were performed using low-fat diet (Zorrilla et al., 2007). Few humans eat low-fat diets, however, and the indirect calorimetric profile of IL-18 null mice is unknown. High-fat diets can produce different rates of energy expenditure as compared with low-fat diets (Bandini et al., 1994, Ebbeling et al., 2012), in relation to the different energy and macronutrient intakes elicited by each. High-fat diets also promote greater relative utilization of lipids as a fuel substrate vs. low-fat diets (McNeill et al., 1988, Rumpler et al., 1991, Verboeket-van de Venne et al., 1994). As a result of these differences, many studies of transgenic mice have observed strikingly different metabolic phenotypes with high-fat diet exposure (Gordon et al., 2008, Klockener et al., 2011, Kusudo et al., 2012, Lee et al., 2007, Paula et al., 2010, Strader et al., 2004, Sutton et al., 2006, Wortley et al., 2004, Zigman et al., 2005). Potentially consistent with a role for IL-18 in metabolic adaptations to high-fat diet, high-fat meals increase circulating IL-18 levels. Therefore, the present study tested the hypothesis that IL-18 null mutation also reduces whole-body energy expenditure and utilization of lipid as a fuel substrate in high-fat diet fed mice.

Energy expenditure can be subdivided into components that reflect the basal metabolic rate of minimally maintaining the organism as compared to phasic components of energy expenditure related to activities of living, including physical activity, thermic effects of food intake and adaptive thermogenesis (Even and Nadkarni, 2012). In our previous study of IL-18 KO mice, whole-body energy metabolism was studied in free-feeding mice, and the genotypes exhibited differences in food intake and motor activity (Zorrilla et al., 2007). Thus, it remains unclear whether phasic components of energy expenditure are responsible for the observed differences in total daily energy expenditure or whether IL-18 KO mice may exhibit a reduced basal metabolic rate. To differentiate between the hypotheses that basal metabolic processes vs. phasic metabolic processes (e.g., activity, absorptive phase of feeding) contribute to IL-18 genotype effects on total daily energy expenditure, the present study measured whole-body energy expenditure of IL-18 KO and wildtype mice under both fasting and feeding conditions within each of the dark cycle and light cycle. Concurrent motor activity was measured.

A third goal was to determine the circadian-dependence of the IL-18 phenotype on food intake and energy expenditure. In our initial study, hyperphagia of low-fat diet was most evident during the mid-to-late dark cycle and respiratory exchange ratios were observed at some, but not other, times of day. On the other hand, genotype differences in energy expenditure of low-fat diet-fed mice and circulating IL-18 levels were consistent across a 24-h period (Zorrilla et al., 2007). Still, circadian variations in sensitivity to IL-18 might exist, as has been seen for IL-1β and IFN-γ (Opp and Toth, 1997). We therefore performed a cosinor analysis of chronobiologic differences in the food intake, energy expenditure, respiratory exchange ratios and motor activity of high-fat diet-fed IL-18 KO vs. wildtype mice.

A final pharmacological study sought to determine whether brain IL-18 systems modulate the control of high-fat diet intake and the mediating role of the IL-18R therein.

Section snippets

Ethical approval

Procedures adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute.

Subjects

Subjects were IL-18 knockout (KO; Il18−/−) mice generated on a C57BL/6J background (Takeda et al., 1998) (from Arturo Zychlinsky, New York University, NY), IL-18 receptor α-subunit KO mice (Il18R−/−), double IL-18/IL-18R KO mice (Il18−/−/Il18R−/−), and their wildtype (WT) littermates.

Body weight

As Table 1 shows, age-matched, chow-reared female Il18−/− mice weighed 32% (7.5 g) more than WT mice at the study onset. By completion of the high-fat diet studies, IL-18 KO weighed 50% (11.4 g) more than WT controls. A Genotype main effect indicated that IL-18 KO mice gained more weight than WT mice (F1,11 = 10.04, p < 0.01), irrespective of the diet available (Genotype X Diet: F1,11 = 0.76, p > 0.40). A Diet main effect reflected that mice of both genotypes gained weight faster during the high-fat

Discussion

The present study confirms that IL-18 deficiency promotes positive energy balance in healthy female mice across times of day and dietary feeding conditions. Chow-reared female IL-18 KO mice were overweight at ∼6 months of age, gained excess weight on both low-fat and high-fat purified diets, ate more high-fat diet, and showed reduced whole-body energy expenditure and decreased relative utilization of lipid as a fuel substrate vs. WT mice. The results further implicate endogenous IL-18 as a

Acknowledgments

We thank Amanda Roberts for help with indirect calorimetry. The work was supported by National Institute of Health grants DK094026, NS43501, and AG28040 as well as The Ellison Medical Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, the National Institute

References (73)

  • I. Presta et al.

    IL-18 gene polymorphism and metabolic syndrome

    Nutr. Metab. Cardiovasc. Dis.

    (2009)
  • M.E. Rashotte et al.

    Daily cycles in body temperature, metabolic rate, and substrate utilization in pigeons: influence of amount and timing of food consumption

    Physiol. Behav.

    (1995)
  • W.V. Rumpler et al.

    Energy-intake restriction and diet-composition effects on energy expenditure in men

    Am. J. Clin. Nutr.

    (1991)
  • S. Sugama et al.

    Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS

    Brain Res.

    (2002)
  • K. Takeda et al.

    Defective NK cell activity and Th1 response in IL-18-deficient mice

    Immunity

    (1998)
  • K. Torigoe et al.

    Purification and characterization of the human interleukin-18 receptor

    J. Biol. Chem.

    (1997)
  • W.P. Verboeket-van de Venne et al.

    Substrate utilization in man: effects of dietary fat and carbohydrate

    Metabolism

    (1994)
  • N. Wang et al.

    Interleukin-18 mRNA expression in the rat pituitary gland

    J. Neuroimmunol.

    (2006)
  • R.D. Wheeler et al.

    Detection of the interleukin 18 family in rat brain by RT-PCR

    Brain Res. Mol. Brain Res.

    (2000)
  • S. Alboni et al.

    Interleukin 18 in the CNS

    J. Neuroinflammation

    (2010)
  • J.R. Arch et al.

    Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals

    Int. J. Obes. (Lond.)

    (2006)
  • D. Arsenijevic et al.

    Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS

    Eur. Cytokine Netw.

    (2000)
  • L.G. Bandini et al.

    Metabolic differences in response to a high-fat vs. a high-carbohydrate diet

    Obes. Res.

    (1994)
  • M.D. Barrachina et al.

    Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice

    Proc. Natl. Acad. Sci. USA

    (1997)
  • R.J. Berger et al.

    Comparative aspects of energy metabolism, body temperature and sleep

    Acta Physiol. Scand. Suppl.

    (1988)
  • T.L. Born et al.

    A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response

    J. Immunol.

    (2000)
  • J.M. Bruun et al.

    Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss

    Eur. J. Endocrinol.

    (2007)
  • A. Chen et al.

    Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior

    J. Neurosci.

    (2006)
  • O. Cheunsuang et al.

    Differential uptake of molecules from the circulation and CSF reveals regional and cellular specialisation in CNS detection of homeostatic signals

    Cell Tissue Res.

    (2006)
  • A.C. Culhane et al.

    Cloning of rat brain interleukin-18 cDNA

    Mol. Psychiatry

    (1998)
  • J. de Metz et al.

    Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans

    J. Appl. Physiol.

    (1999)
  • C.B. Ebbeling et al.

    Effects of dietary composition on energy expenditure during weight-loss maintenance

    JAMA

    (2012)
  • K. Esposito et al.

    Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

    Circulation

    (2002)
  • K. Esposito et al.

    Weight loss reduces interleukin-18 levels in obese women

    J. Clin. Endocrinol. Metab.

    (2002)
  • K. Esposito et al.

    Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

    JAMA

    (2003)
  • J. Evans et al.

    The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease

    Eur. J. Endocrinol.

    (2007)
  • Cited by (30)

    • Inflammatory cytokines and appetite in older hospitalized patients

      2021, Appetite
      Citation Excerpt :

      Further, the regulative role of IL-18 on appetite and feeding has been also demonstrated in other animal studies. Francesconi et al. and others previously showed that IL-18 controls energy homeostasis by suppressing appetite and feed efficiency and promoting energy expenditure in mice (Francesconi et al., 2016; Netea et al., 2006; Zorrilla & Conti, 2014; Zorrilla et al., 2007). Although there is a lack of studies on IL-18 as an anorectic agent in humans, it seems that IL-18 regulates energy intake and energy homeostasis in diseased subjects.

    • Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels

      2020, Journal of Biological Chemistry
      Citation Excerpt :

      IL-18 receptor knockout mice show metabolic disorder, inflammation, and insulin resistance arising from mechanisms involving the activation of adenosine monophosphate activated protein kinase (AMPK) in skeletal muscle (24). Similarly, IL-18 knockout leads to obesity and insulin resistance (12, 32). Moreover, IL-18 may promote hepatic cell proliferation in rat liver regeneration (33).

    • Ablation of β,β-carotene-9′,10′-oxygenase 2 remodels the hypothalamic metabolome leading to metabolic disorders in mice

      2017, Journal of Nutritional Biochemistry
      Citation Excerpt :

      Glycerophosphoserines are involved in cell signaling, especially during macrophage recognition of cells undergoing apoptosis [51]. Like IL-1β, IL-18 belongs to the IL-1 family and is produced by activation of inflammasomes 1 and/or 3 [52–54]. Intracerebroventricular or peripheral administration of IL-18 suppresses appetite and promotes energy expenditure [54].

    • The modern interleukin-1 superfamily: Divergent roles in obesity

      2016, Seminars in Immunology
      Citation Excerpt :

      One IL-18BP can only bind to one free IL-18 cytokine and therefore makes it simple to measure how much free IL-18 versus bound IL-18 is present in the serum [65,66]. IL-18 has recently been identified as a key player in metabolic homeostasis [12,13]. In obesity, clinical studies show that obesity is strongly associated with high serum levels of IL-18 [67] and that massive weight loss in morbidly obese patients by bariatric surgery [12] or 12-week diet-induced weight loss program in obese females [68], result in a significant reduction in serum IL-18.

    View all citing articles on Scopus
    View full text